ANL CIK: 1944552

Adlai Nortye Group Ltd.

  • Singapore
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−0.61
FY23:
–
FY24:
−0.51
FY25:
4.52
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.65
FY22:
−67.3
FY23:
−72.6
FY24:
−52.9
FY25:
−35.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−54.3
FY22:
−57.4
FY23:
–
FY24:
−48.1
FY25:
−32.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.7
FY22:
−58.8
FY23:
−109
FY24:
−51.9
FY25:
−35.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.7
FY22:
−58.8
FY23:
−109
FY24:
−51.9
FY25:
−35.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data